Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,480 | 438 | 4,428 | 1,888 | N/A |
| Receivables | 0 | 1 | 1 | 48 | N/A |
| Other current assets | 60 | 51 | 190 | 193 | 0 |
| TOTAL | $1,540 | $490 | $4,619 | $2,129 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 220 | 422 | 300 | 0 | N/A |
| Investments And Advances | 150 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 428 | 0 | 0 | 0 | 0 |
| TOTAL | $798 | $422 | $300 | $N/A | $N/A |
| Total Assets | $2,350 | $1,447 | $4,928 | $2,129 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 390 | 0 | 0 | 136 | 0 |
| Accrued Expenses | 30 | N/A | N/A | 227 | N/A |
| Other current liabilities | 0 | N/A | N/A | 73 | N/A |
| TOTAL | $530 | $706 | $675 | $436 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | N/A | 7 | N/A |
| TOTAL | $20 | $N/A | $N/A | $7 | $N/A |
| Total Liabilities | $550 | $706 | $675 | $443 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 30 | 1,304 | 1,256 | 350 | N/A |
| Retained earnings | -23,140 | N/A | N/A | -39,026 | N/A |
| Other shareholders' equity | 0 | -705 | 2,804 | -5 | 0 |
| TOTAL | $1,790 | $599 | $4,060 | $1,686 | $N/A |
| Total Liabilities And Equity | $2,340 | $1,305 | $4,735 | $2,129 | $0 |